title: Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantation.
authors.affiliation: Medizinische Klinik IV, Institut für Infektionsmedizin, Institut für Klinische Chemie und Pathobiochemie, Universitätsklinikum Benjamin Franklin, Freie Universität, Berlin, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Jung
authors.forename: E
authors.initials: E
authors.lastname: Engelmann
authors.forename: K
authors.initials: K
authors.lastname: Borner
authors.forename: G
authors.initials: G
authors.lastname: Offermann
mesh_terms: D000284:Administration, Oral; D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use*; D003365:Costs and Cost Analysis; D003586:Cytomegalovirus Infections / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D015774:Ganciclovir / Q000191:economics / Q000627:therapeutic use*; D005858:Germany; D006801:Humans; D016030:Kidney Transplantation / Q000502:physiology*; D011183:Postoperative Complications / Q000517:prevention & control* / Q000821:virology
chemical_list: D000998:Antiviral Agents; D015774:Ganciclovir